Is nitric oxide important in photodynamic therapy?

Journal of Photochemistry and Photobiology B: Biology

Volumn 95, Issue 3, 2009, Pages 141-147

  Reeves, Kimberley J ^a   Reed, Malcolm W R ^a   Brown, Nicola J ^a  

^a Academic Unit of Haematology   (United Kingdom)

Author keywords

Nitric oxide; Nitric oxide synthase inhibitors; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ETIOPURPURIN; FLAVINE MONONUCLEOTIDE; FREE RADICAL; HEME; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPID; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NUCLEIC ACID; OXYGEN; PHOTOFRIN; PHOTOSENSITIZING AGENT; PHTHALOCYANINE; PROTEIN; PROTOPORPHYRIN; PURLYTIN; REACTIVE OXYGEN METABOLITE; SINGLET OXYGEN; TEMOPORFIN; TETRAHYDROBIOPTERIN; UNCLASSIFIED DRUG; VERTEPORFIN;

ACTINIC KERATOSIS; BARRETT ESOPHAGUS; BASAL CELL CARCINOMA; BLADDER CANCER; BLADDER TUMOR; BLOOD VESSEL INJURY; BRAIN TUMOR; BREAST CANCER; BRONCHUS CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CANCER PALLIATIVE THERAPY; CHEMICAL INTERACTION; COLON ADENOCARCINOMA; DERMATOLOGY; ENERGY TRANSFER; ENZYME INHIBITION; ESOPHAGUS CANCER; FIBROSARCOMA; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HEAD AND NECK TUMOR; HUMAN; KAPOSI SARCOMA; LEUKOCYTE MIGRATION; LUNG CANCER; NONHUMAN; ONCOLOGY; OPHTHALMOLOGY; OXIDATIVE STRESS; PANCREAS TUMOR; PHOTOCHEMISTRY; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE TUMOR; QUALITY OF LIFE; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SKIN DEFECT; SKIN INFLAMMATION; SKIN METASTASIS; SKIN NECROSIS; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; TISSUE INJURY; TREATMENT OUTCOME; TUMOR CELL; TUMOR GROWTH; TUMOR VOLUME; UTERINE CERVIX CANCER; UTERINE CERVIX DYSPLASIA;

NEOPLASMS; NITRIC OXIDE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 67349237199     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2009.02.005     Document Type: Review

References (84)

1. Henderson B.W., and Dougherty T.J. How does photodynamic therapy work?. Photochem. Photobiol. 55 (1992) 145-157
2. Pass H.I. Photodynamic therapy in oncology: mechanisms and clinical use. J. Natl. Cancer Inst. 85 (1993) 443-456
3. Fisher A.M., Murphree A.L., and Gomer C.J. Clinical and preclinical photodynamic therapy. Lasers Surg. Med. 17 (1995) 2-31
4. Luo Y., and Kessel D. Initiation of apoptosis versus necrosis by photodynamic therapy with chloroaluminum phthalocyanine. Photochem. Photobiol. 66 (1997) 479-483
5. Kessel D., Luo Y., Deng Y., and Chang C.K. The role of subcellular localization in initiation of apoptosis by photodynamic therapy. Photochem. Photobiol. 65 (1997) 422-426
6. Ignarro L.J. Endothelium-derived nitric oxide: actions and properties. FASEB J. 3 (1989) 31-36
7. Bertuglia S., Colantuoni A., and Intaglietta M. Capillary reperfusion after l-arginine, l-NMMA, and l-NNA treatment in cheek pouch microvasculature. Microvasc. Res. 50 (1995) 162-174
8. Fukumura D., Yuan F., Endo M., and Jain R.K. Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions. Am. J. Pathol. 150 (1997) 713-725
9. Tozer G.M., Prise V.E., Bell K.M., Dennis M.F., Stratford M.R., and Chaplin D.J. Reduced capacity of tumour blood vessels to produce endothelium-derived relaxing factor: significance for blood flow modification. Br. J. Cancer 74 (1996) 1955-1960
10. Sneddon J.M., and Vane J.R. Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. Proc. Natl. Acad. Sci. USA 85 (1998) 2800-2804
11. Kubes P., Suzuki M., and Granger D.N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA 88 (1991) 4651-4655
12. Thomsen L.L., Lawton F.G., Knowles R.G., Beesley J.E., Riveros-Moreno V., and Moncada S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res. 54 (1994) 1352-1354
13. Thomsen L.L., Miles D.W., Happerfield L., Bobrow L.G., Knowles R.G., and Moncada S. Nitric oxide synthase activity in human breast cancer. Br. J. Cancer 72 (1995) 41-44
14. Cobbs C.S., Brenman J.E., Aldape K.D., Bredt D.S., and Israel M.A. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res. 55 (1995) 727-730
15. Rosbe K.W., Prazma J., Petrusz P., Mims W., Ball S.S., and Weissler M.C. Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck. Otolaryngol. Head Neck Surg. 113 (1995) 541-549
16. Tozer G.M., and Everett S.A. Nitric oxide in tumor biology and cancer therapy. Part 2: Therapeutic implications. Clin. Oncol. (Roy. Coll. Radiol.) 9 (1997) 357-364
17. Parkins C.S., Dennis M.F., Stratford M.R., Hill S.A., and Chaplin D.J. Ischemia reperfusion injury in tumors: the role of oxygen radicals and nitric oxide. Cancer Res. 55 (1995) 6026-6029
18. Korbelik M., Parkins C.S., Shibuya H., Cecic I., Stratford M.R., and Chaplin D.J. Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy. Br. J. Cancer 82 (2002) 1835-1843
19. Korbelik M., and Cecic I. Enhancement of tumour response to photodynamic therapy by adjuvant mycobacterium cell-wall treatment. J. Photochem. Photobiol. B 44 (1998) 151-158
20. Radomski M.W., Palmer R.M., and Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2 (1987) 1057-1058
21. Siney L., and Lewis M.J. Endothelium-derived relaxing factor inhibits platelet adhesion to cultured porcine endocardial endothelium. Eur. J. Pharmacol. 229 (1992) 223-226
22. Fukumura D., and Jain R.K. Role of nitric oxide in angiogenesis and microcirculation in tumors. Cancer Metast. Rev. 17 (1998) 77-89
23. Peng H.B., Spiecker M., and Liao J.K. Inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation. J. Immunol. 161 (1998) 1970-1976
24. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., Moan J., and Peng Q. Photodynamic therapy. J. Natl. Cancer Inst. 90 (1998) 889-905
25. Henderson B.W., Sitnik-Busch T.M., and Vaughan L.A. Potentiation of photodynamic therapy antitumor activity in mice by nitric oxide synthase inhibition is fluence rate dependent. Photochem. Photobiol. 70 (1990) 64-71
26. Korbelik M., Shibuya H., and Cecic I. Relevance of nitric oxide to the response of tumours to photodynamic therapy. SPIE 3247 (1998) 98-105
27. Sibata C.H., Colussi V.C., Oleinick N.L., and Kinsella T.J. Photodynamic therapy in oncology. Exp. Opin. Pharmacother. 2 (2001) 917-927
28. Wolfsen H.C. Uses of photodynamic therapy in premalignant and malignant lesions of the gastrointestinal tract beyond the esophagus. J. Clin. Gastroenterol. 39 (2005) 653-664
29. Dougherty T.J. Photosensitizers: therapy and detection of malignant tumors. Photochem. Photobiol. 45 (1987) 879-889
30. Dougherty T.J., Cooper M.T., and Mang T.S. Cutaneous phototoxic occurrences in patients receiving Photofrin. Lasers Surg. Med. 10 (1990) 485-488
31. Vogl T.J., Eichler K., Mack M.G., Zangos S., Herzog C., Thalhammer A., and Engelmann K. Interstitial photodynamic laser therapy in interventional oncology. EUR Radiol. 14 (2004) 1063-1073
32. Castano A.P., Mroz P., and Hamblin M.R. Photodynamic therapy and anti-tumour immunity. Nat. Rev. Cancer 6 (2006) 535-545
33. Radomski M.W., and Salas E. Nitric oxide-biological mediator, modulator and factor of injury: its role in the pathogenesis of atherosclerosis. Atherosclerosis 118 (1995) S69-S80
34. Niziolek M., Korytowski W., and Girotti A.W. Nitric oxide-induced resistance to lethal photooxidative damage in a breast tumor cell line. Free Rad. Biol. 40 (2006) 1323-1331
35. Palmer R.M., Ferrige A.G., and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327 (1987) 524-526
36. Bredt D.S., and Snyder S.H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA 87 (1990) 682-685
37. Marletta M.A., Yoon P.S., Iyengar R., Leaf C.D., and Wishnok J.S. Macrophage oxidation of l-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 27 (1988) 8706-8711
38. Geller D.A., Nguyen D., Shapiro R.A., Nussler A., Di Silvio M., Freeswick P., Wang S.C., Tweardy D.J., Simmons R.L., and Billiar T.R. Cytokine induction of interferon regulatory factor-1 in hepatocytes. Surgery 114 (1993) 235-242
39. Nakayama D.K., Geller D.A., Lowenstein C.J., Chern H.D., Davies P., Pitt B.R., Simmons R.L., and Billiar T.R. Cytokines and lipopolysaccharide induce nitric oxide synthase in cultured rat pulmonary artery smooth muscle. Am. J. Respir. Cell. Mol. Biol. 7 (1992) 471-476
40. Stadler J., Stefanovic-Racic M., Billiar T.R., Curran R.D., McIntyre L.A., Georgescu H.I., Simmons R.L., and Evans C.H. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J. Immunol. 147 (1991) 3915-3920
41. Balligand J.L., Kelly R.A., Marsden P.A., Smith T.W., and Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc. Natl. Acad. Sci. USA 90 (1993) 347-351
42. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6 (1992) 3051-3064
43. Radomski M.W., Palmer R.M., and Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. USA 87 (1990) 10043-10047
44. Billiar T.R., Curran R.D., West M.A., Hofmann K., and Simmons R.L. Kupffer cell cytotoxicity to hepatocytes in coculture requires l-arginine. Arch. Surg. 124 (1989) 1416-1420
45. Curran R.D., Billiar T.R., Stuehr D.J., Hofmann K., and Simmons R.L. Hepatocytes produce nitrogen oxides from l-arginine in response to inflammatory products of Kupffer cells. J. Exp. Med. 170 (1989) 1769-1774
46. Davies M.G., Fulton G.J., and Hagen P.O. Clinical biology of nitric oxide. Br. J. Surg. 82 (1995) 1598-1610
47. Tozer G.M., and Everett S.A. Nitric oxide in tumour biology and cancer therapy. Part 1: Physiological aspects. Clin. Oncol. (Roy. Coll. Radiol.) 9 (1997) 282-293
48. Lu Z., Tao Z.Y., Zhou Z., Zhang J., Li C., Ou L., and Zhao B. Mitochondrial reactive oxygen species and nitric oxide-mediated cancer cell apoptosis in 2-butylamino-2-demethoxyhypocrellin B photodynamic treatment. Free Rad. Biol. Med. 41 (2006) 1590-1605
49. Sutherland R.M., Rasey J.S., and Hill R.P. Tumor biology. Am. J. Clin. Oncol. 11 (1988) 253-274
50. Stuehr D.J., and Marletta M.A. Synthesis of nitrite and nitrate in murine macrophage cell lines. Cancer Res. 47 (1987) 5590-5594
51. Radomski M.W., Jenkins D.C., Holmes L., and Moncada S. Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res. 51 (1991) 6073-6078
52. Buttery L.D., Springall D.R., Andrade S.P., Riveros-Moreno V., Hart I., Piper P.J., and Polak J.M. Induction of nitric oxide synthase in the neo-vasculature of experimental tumours in mice. J. Pathol. 171 (1993) 311-319
53. Moochhala S., Chhatwal V.J., Chan S.T., Ngoi S.S., Chia Y.W., and Rauff A. Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogenesis 17 (1996) 1171-1174
54. Less J.R., Skalak T.C., Sevick E.M., and Jain R.K. Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Res. 51 (1990) 265-273
55. Lejeune P., Lagadec P., Onier N., Pinard D., Ohshima H., and Jeannin J.F. Nitric oxide involvement in tumor-induced immunosuppression. J. Immunol. 152 (1994) 5077-5083
56. Thomsen L.L., Scott J.M., Topley P., Knowles R.G., Keerie A.J., and Frend A.J. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res. 57 (1997) 3300-3304
57. Cui S., Reichner J.S., Mateo R.B., and Albina J.E. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res. 54 (1994) 2462-2467
58. Xie K., Huang S., Dong Z., Juang S.H., Gutman M., Xie Q.W., Nathan C., and Fidler I.J. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med. 181 (1995) 1333-1343
59. Jenkins D.C., Charles I.G., Thomsen L.L., Moss D.W., Holmes L.S., Baylis S.A., Rhodes P., Westmore K., Emson P.C., and Moncada S. Roles of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. USA 92 (1995) 4392-4396
60. Di Venosa G., Casas A., Fukuda H., Perotti C., and Batlle A. No cross-resistance between ALA-mediated photodynamic therapy and nitric oxide. Nitric Oxide 13 (2005) 155-162
61. Di Venosa G., Perotti C., Fukuda H., Batlle A., and Casas A. Sensitivity to ALA-PDT of cell lines with different nitric oxide production and resistance to NO cytotoxicity. J. Photochem. Photobiol. B 80 (2005) 195-202
62. Yamamoto F., Ohgari Y., Yamaki N., Kitajima S., Shimokawa O., Matsui H., and Taketani S. The role of nitric oxide in delta-aminolevulinic acid (ALA)-induced photosensitivity of cancerous cells. Biochem. Biophys. Res. Commun. 16 (2007) 541-546
63. Krosl G., Korbelik M., and Dougherty G.J. Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy. Br. J. Cancer 71 (1995) 549-555
64. Gollnick S.O., Liu X., Owczarczak B., Musser D.A., and Henderson B.W. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res. 57 (1997) 3904-3909
65. Moilanen E., Vuorinen P., Kankaanranta H., Metsa-Ketela T., and Vapaatalo H. Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions. Br. J. Pharmacol. 109 (1993) 852-858
66. Fingar V.H., Wieman T.J., Wiehle S.A., and Cerrito P.B. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res. 52 (1992) 4914-4921
67. Marks D.S., Vita J.A., Folts J.D., Keaney J.F., Welch G.N., and Loscalzo J. Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide. J. Clin. Invest. 96 (1995) 2630-2638
68. Hirst D.G., and Flitney F.W. The physiological importance and therapeutic potential of nitric-oxide in tumour-associated vasculature. In: Bicknell R., Lewis C.E., and Ferrara N. (Eds). Tumour Angiogenesis (1997), Oxford, Oxford University Press 153-167
69. Gupta S., Ahmad N., and Mukhtar H. Involvement of nitric oxide during phthalocyanine (Pc4) photodynamic therapy-mediated apoptosis. Cancer Res. 58 (1998) 1785-1788
70. Grisham M.B., Hernandez L.A., and Granger D.N. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am. J. Physiol. 251 (1986) G567-G574
71. Athar M., Mukhtar H., Elmets C.A., Zaim M.T., Lloyd J.R., and Bickers D.R. In situ evidence for the involvement of superoxide anions in cutaneous porphyrin photosensitization. Biochem. Biophys. Res. Commun. 151 (1988) 1054-1059
72. Parkins C.S., Hill S.A., Stratford M.R., Dennis M.F., and Chaplin D.J. Metabolic and clonogenic consequences of ischaemia reperfusion insult in solid tumours. Exp. Physiol. 82 (1997) 361-368
73. Korbelik M., Sun J., and Zeng H. Ischaemia-reperfusion injury in photodynamic therapy-treated mouse tumours. Br. J. Cancer 88 (2003) 760-766
74. Woodhams J.H., Kunz L., Bown S.G., and MacRobert A.J. Correlation of real-time haemoglobin oxygen saturation monitoring during photodynamic therapy with microvascular effects and tissue necrosis in normal rat liver. Br. J. Cancer 91 (2004) 788-794
75. Athar M., Elmets C.A., Bickers D.R., and Mukhtar H. A novel mechanism for the generation of superoxide anions in hematoporphyrin derivative-mediated cutaneous photosensitization. Activation of the xanthine oxidase pathway. J. Clin. Invest. 83 (1989) 1137-1143
76. McCall T.B., Boughton-Smith N.K., Palmer R.M., Whittle B.J., and Moncada S. Synthesis of nitric oxide from l-arginine by neutrophils. Release and interaction with superoxide anion. Biochem. J. 261 (1989) 293-296
77. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., and Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87 (1990) 1620-1624
78. Beckman J.S., and Crow J.P. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem. Soc. Trans. 21 (1993) 330-334
79. Gaboury J.P., Anderson D.C., and Kubes P. Molecular mechanisms involved in superoxide-induced leukocyte-endothelial cell interactions in vivo. Am. J. Physiol. 266 (1994) H637-H642
80. Kurose I., Wolf R., Grisham M.B., and Granger D.N. Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circ. Res. 74 (1994) 376-382
81. Dalbasti T., Cagli S., Kilinc E., Oktar N., and Ozsoz M. Online electrochemical monitoring of nitric oxide during photodynamic therapy. Nitric Oxide 7 (2002) 301-305
82. Gilissen M.J., van de Merbel-de Wit L.E., Star W.M., Koster J.F., and Sluiter W. Effect of photodynamic therapy on the endothelium-dependent relaxation of isolated rat aortas. Cancer Res. 53 (1993) 2548-2552
83. Reeves K.J., Reed M.W., and Brown N.J. Role of Nitric Oxide (NO) inhibition on Aminolaevulinic Acid (ALA-PDT) in vivo. Angiogenesis 9 (2006) 28
84. Reeves K.J., Reed M.W., and Brown NJ N.J. Detection of iNOS and eNOS following ALA-PDT in combination with NOS inhibition. Microcirculation 14 (2007) 649